Trial · NCT07889570
A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression
NCT07889570, Not applicable, Completed, Evolv
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression. Trials, record NCT07889570. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889570
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression
- NCT number
- NCT07889570
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 98 participants, actual
- Lead sponsor
- Evolv
- Conditions
- Overweight, Obesity, Blood Sugar Regulation, Appetite Suppression, Weight Management
- Interventions
- Evolv GLP-1 Group, Control Group
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Hemoglobin A1c (HgbA1c) | Baseline, Week 6, and Week 12 | Change from Baseline in HgbA1c measured via blood draw at a Labcorp location center |
| Primary | Change in Body Weight | Baseline, Week 4, Week 6, Week 8, and Week 12 | Change from Baseline in body weight measured at home using a provided Withings scale; average of three consecutive daily measurements taken at each time point |
| Primary | Change in Waist Circumference | Baseline, Week 4, Week 6, Week 8, and Week 12 | Change from Baseline in waist circumference measured at home using a provided tape measure |
| Secondary | Participant Perception of Effect on Weight Loss | Baseline, Week 4, Week 6, Week 8, and Week 12 | Self-reported perception of the product's effect on weight loss assessed via study-specific questionnaire |
| Secondary | Participant Perception of Effect on Appetite Suppression | Baseline, Week 4, Week 6, Week 8, and Week 12 | Self-reported perception of the product's effect on appetite suppression including curbing cravings assessed via study-specific questionnaire |
| Secondary | Participant Perception of Effect on Blood Sugar | Baseline, Week 4, Week 6, Week 8, and Week 12 | Self-reported perception of the product's effect on blood sugar assessed via study-specific questionnaire |
| Secondary | Participant Perception of Effect on Overall Well-Being | Baseline, Week 4, Week 6, Week 8, and Week 12 | Self-reported perception of the product's effect on other outcomes related to well-being assessed via study-specific questionnaire |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889570
GET https://conductscience.org/api/trials/v1/NCT07889570/registered